Creutzfeldt-Jakob disease (CJD) is a spongiform encephalopathy that results in a rapidly progressive dementia and other non-specific neurological features and death usually within a year or less from onset. The vast majority are sporadic, but familial and acquired forms are also occasionally encountered.
On imaging, it classically manifests as T2/FLAIR hyperintensities within the basal ganglia, thalamus, and cortex. These lesions show diffusion restriction on DWI/ADC sequences.
Four types of Creutzfeldt-Jakob disease have been described 2,6:
- sporadic (sCJD)
- accounts for 85-90% of cases
- further divided into numerous subtypes according to molecular markers (see pathology section below)
- variant (vCJD)
- bovine-to-human transmission of bovine spongiform encephalopathy (aka mad cow disease)
- especially if in the UK between 1981-1996
- subsequent human-to-human transmission (e.g. transfusion) of vCJD
- familial (fCJD)
- 10% of cases
- these individuals carry a PRPc mutation
- iatrogenic (iCJD)
- following administration of cadaveric human pituitary hormones (pre-1985)
- various transplants
Creutzfeldt-Jakob disease is characterized by rapidly progressive dementia, cerebral atrophy, myoclonus, and death. Patients with vCJD present mostly with sensory and psychiatric symptoms; patients with sCJD usually present with progressive cognitive impairment and cerebellar symptoms. Cerebellar symptoms may often be prominent and early in patients with iCJD secondary to cadaveric human pituitary hormones.
Additionally, various distinct clinical patterns have been linked to various molecular subtypes (e.g. Heidenhain variant linked to MM1 and MM 2C 18).
- characteristic results on electroencephalography (EEG)
- CSF 14-3-3 protein: positive result in patient suspected clinically of having sCJD
- CSF and/or olfactory mucosa real time quaking-induced conversion (RT-QuIC) seeding assays: detects minute amounts of the disease-specific pathologic prion protein 12,13
- found to be more sensitive than CSF 14-3-3 protein titers 12
A definitive diagnosis requires a brain biopsy, although in many institutions the difficulty involved in sterilizing equipment renders a biopsy undesirable.
CJD is thought to be mediated via prions, a type of protein, which manifests in sheep as the disease scrapie, and in cows as bovine spongiform encephalopathy. Prions are considered infectious in the sense that they can alter the structure of neighboring proteins.
CJD leads to spongiform degeneration of the brain, which is thought to be caused by the conversion of normal prion protein to proteinaceous infectious particles that accumulate in and around neurons and lead to cell death.
A number of subtypes of sporadic CJD are recognized based on molecular markers, and these have distinct clinical and pathological features. The classification is based on 16,17:
- codon 129 in the prion protein gene
- methionine (M) or valine (V)
- size of the protease-resistant core of the abnormal prion protein
- PrPSc type 1 (21 kDa) or type 2 (19 kDa)
Each variant of sporadic CJD results from the combination of codon 129 genotype (M or V) and PrPSc type (1, 2 or 1 + 2) 16,17.
Additionally, MM2 subtype as has been noted to have distinctive histopathological features affecting the cerebral cortex and the thalamus and have therefore been separated into MM2 cortical (MM 2C) and MM2 thalamic (MM 2T).
Mixed types are also encountered. The result is that there is significant variation in the literature in regards to how many subtypes there are and if and how they should be grouped together 17.
MRI findings may be bilateral or unilateral and symmetric or asymmetric, and include:
- T2: hyperintensity
- DWI/ADC: persistent restricted diffusion (considered the most sensitive sign)
Review of sequential studies also typically demonstrates rapidly progressive cerebral atrophy.
- hypometabolism on 18FDG-PET studies
Treatment and prognosis
There is currently no curative treatment and the disease is invariably fatal with a mean survival of only 7 months for most cases.
CJD is a notifiable disease in most countries, including European Union countries, Australia, United Kingdom, USA, and Canada.
History and etymology
It was named after Hans Gerhard Creutzfeldt (1885-1964), a German neurologist who first described the condition in 1920, and Alfons Maria Jakob (1884-1931), a German neurologist who also described the condition in a separate study in 1921 14,15.
MRI imaging features overlap with many other conditions but the presentation will be different 10,11:
- 1. Grossman RI, Yousem DM. Neuroradiology, the requisites. Mosby Inc. (2003) ISBN:032300508X. Read it at Google Books - Find it at Amazon
- 2. Lee H, Hoffman C, Kingsley PB et-al. Enhanced detection of diffusion reductions in Creutzfeldt-Jakob disease at a higher B factor. AJNR Am J Neuroradiol. 2010;31 (1): 49-54. doi:10.3174/ajnr.A1756 - Pubmed citation
- 3. Kallenberg K, Schulz-schaeffer WJ, Jastrow U et-al. Creutzfeldt-Jakob disease: comparative analysis of MR imaging sequences. AJNR Am J Neuroradiol. 2006;27 (7): 1459-62. AJNR Am J Neuroradiol (full text) - Pubmed citation
- 4. Finkenstaedt M, Szudra A, Zerr I et-al. MR imaging of Creutzfeldt-Jakob disease. Radiology. 1996;199 (3): 793-8. Radiology (abstract) - Pubmed citation
- 5. Tschampa HJ, Kallenberg K, Kretzschmar HA et-al. Pattern of cortical changes in sporadic Creutzfeldt-Jakob disease. AJNR Am J Neuroradiol. 28 (6): 1114-8. doi:10.3174/ajnr.A0496 - Pubmed citation
- 6. Ukisu R, Kushihashi T, Tanaka E et-al. Diffusion-weighted MR imaging of early-stage Creutzfeldt-Jakob disease: typical and atypical manifestations. Radiographics. 2006;26 Suppl 1 : S191-204. doi:10.1148/rg.26si065503 - Pubmed citation
- 7. Muayqil T, Gronseth G, Camicioli R. Evidence-based guideline: Diagnostic accuracy of CSF 14-3-3 protein in sporadic Creutzfeldt-Jakob disease: Report of the Guideline Development Subcommittee of the American Academy of Neurology. Neurology. 2012;79 (14): 1499-506. doi:10.1212/WNL.0b013e31826d5fc3 - Pubmed citation
- 8. Vitali P, Maccagnano E, Caverzasi E et-al. Diffusion-weighted MRI hyperintensity patterns differentiate CJD from other rapid dementias. Neurology. 2011;76 (20): 1711-9. doi:10.1212/WNL.0b013e31821a4439 - Free text at pubmed - Pubmed citation
- 9. Osborn A. Osborn's Brain. Lippincott Williams & Wilkins. ISBN:1931884218. Read it at Google Books - Find it at Amazon
- 10. Tschampa HJ, Kallenberg K, Urbach H et-al. MRI in the diagnosis of sporadic Creutzfeldt-Jakob disease: a study on inter-observer agreement. Brain. 2005;128 (9): 2026-33. doi:10.1093/brain/awh575 - Pubmed citation
- 11. Castillo M. Neuroradiology Companion: Methods, Guidelines, and Imaging Fundamentals. LWW. ISBN:1451111754. Read it at Google Books - Find it at Amazon
- 12. McGuire LI, Peden AH, Orrú CD, Wilham JM, Appleford NE, Mallinson G, Andrews M, Head MW, Caughey B, Will RG, Knight RS, Green AJ. Real time quaking-induced conversion analysis of cerebrospinal fluid in sporadic Creutzfeldt-Jakob disease. Annals of neurology. 72 (2): 278-85. doi:10.1002/ana.23589 - Pubmed
- 13. Schmitz M, Cramm M, Llorens F, Müller-Cramm D, Collins S, Atarashi R, Satoh K, Orrù CD, Groveman BR, Zafar S, Schulz-Schaeffer WJ, Caughey B, Zerr I. The real-time quaking-induced conversion assay for detection of human prion disease and study of other protein misfolding diseases. Nature Protocols. 11 (11): 2233. doi:doi:10.1038/nprot.2016.120
- 14. Creutzfeldt HG. Über eine eigenartige herdförmige erkrankung des zentralnervensystems (Vorläufige mitteilung). Zeitschrift für die gesamte Neurologie und Psychiatrie. 57 (1): 1. doi:10.1007/BF02866081
- 15. Jakob, ADZ. Über eigenartige Erkrankunbgen des Zentralnervensystems mit bemerkens- wertem anatomischen Befunde. Nervenheilk. 70, 132-146 (1921).
- 16. Parchi P, de Boni L, Saverioni D, Cohen ML, Ferrer I, Gambetti P, Gelpi E, Giaccone G, Hauw JJ, Höftberger R, Ironside JW, Jansen C, Kovacs GG, Rozemuller A, Seilhean D, Tagliavini F, Giese A, Kretzschmar HA. Consensus classification of human prion disease histotypes allows reliable identification of molecular subtypes: an inter-rater study among surveillance centres in Europe and USA. (2012) Acta neuropathologica. 124 (4): 517-29. doi:10.1007/s00401-012-1002-8 - Pubmed
- 17. Hill, Andrew F., Joiner, Susan, Wadsworth, Jonathan D. F., Sidle, Katie C. L., Bell, Jeanne E., Budka, Herbert, Ironside, James W., Collinge, John. Molecular classification of sporadic Creutzfeldt–Jakob disease. (2003) Brain. 126 (6): 1333. doi:10.1093/brain/awg125 - Pubmed
- 18. Baiardi S, Capellari S, Ladogana A, Strumia S, Santangelo M, Pocchiari M, Parchi P. Revisiting the Heidenhain Variant of Creutzfeldt-Jakob Disease: Evidence for Prion Type Variability Influencing Clinical Course and Laboratory Findings. (2016) Journal of Alzheimer's disease : JAD. 50 (2): 465-76. doi:10.3233/JAD-150668 - Pubmed
Related Radiopaedia articles
Neurodegenerative diseases are legion and their classification just as protean. A useful approach is to divide them according to underlying pathological process, although even using this schema, there is much overlap and thus resulting confusion.
neurodegenerative MRI brain (an approach)
- measurements and ratios
- midbrain to pons area ratio (for PSP)
- Magnetic Resonance Parkinsonism Index (MRPI) (for PSP)
- frontal horn width to intercaudate distance ratio (FH/CC) (for Huntington disease)
- intercaudate distance to inner table width ratio (CC/IT) (for Huntington disease)
- scoring systems
- measurements and ratios
- typical/classical Alzheimer disease
- variant (e.g. posterior cortical atrophy)
- chronic traumatic encephalopathy (CTE)
- corticobasal degeneration
- frontotemporal lobar degeneration (FTLD) (not all are tau)
- Pick disease
- progressive supranuclear palsy (PSP)
- Alzheimer disease
- cerebral amyloid angiopathy (CAA)
- transthyretine-associated cerebral amyloidosis
- neuronal intranuclear hyaline inclusion disease (NIHID)
- TDP-43 proteinopathies
- spinocerebellar ataxias
- Huntington disease
- hereditary spastic paraplegia
- clinically unclassifiable parkinsonism (CUP)
- Unverricht-Lundborg disease
- prion diseases (not always included as neurodegenerative)
Infections of the central nervous system
- classification by etiology
- Eastern equine encephalitis
- enterovirus rhombencephalitis
- flavivirus encephalitis
herpes virus family
- herpes simplex virus 1 (HSV-1) encephalitis
- herpes simplex virus 2 (HSV-2) encephalitis
- varicella zoster virus (VZV) encephalitis
- Epstein-Barr virus (EBV) encephalitis
- cytomegalovirus (CMV) encephalitis
- human herpesvirus 6 (HHV-6) encephalitis
- HIV CNS manifestations
- HTLV-1-associated myelopathy
- JC virus
- measles encephalitis
- Nipah virus (NiV) encephalitis
- rabies encephalitis
- CNS listeriosis (Listeria monocytogenes)
- CNS nocardiosis (Nocardia spp)
- CNS tuberculosis (Mycobacterium tuberculosis)
- Lyme disease (Borrelia burgdorferi)
- neurobrucellosis (Brucella sp.)
- neurosyphilis (Treponema pallidum)
- Rocky Mountain spotted fever (Rickettsia rickettsii)
- cerebral amoebiasis
- cerebral malaria (Plasmodium falciparum)
- cerebral sparganosis (Spirometra mansonoides)
- neurocysticercosis (Taenia solium)
- neurohydatidosis (Echinococcus spp)
- neurotoxoplasmosis (Toxoplasma gondii)
- others or those with possible infectious etiologies
- classification by location
- classification by etiology